Back
Sarepta Therapeutics Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
37
SRPT
Sarepta Therapeutics
Last Price:
132.04
Seasonality Move:
9.41%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.4 | Buy |
| 20-day SMA: | 123.6 | Buy |
| 50-day SMA: | 128.94 | Buy |
| 200-day SMA: | 130.02 | Sell |
| 8-day EMA: | 126.58 | Buy |
| 20-day EMA: | 125.36 | Buy |
| 50-day EMA: | 128.32 | Buy |
| 200-day EMA: | 127.84 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 59.84 | Buy |
| Chaikin Money Flow: | 345786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.92 - 127.2) | Buy |
| Bollinger Bands (100): | (122.48 - 147.12) | Sell |
Sarepta Therapeutics Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 129.88 while SRPT 8-day simple moving average is 126.40, which is a Buy signal.
- The stock price of SRPT is 129.88 while Sarepta Therapeutics 20-day SMA is 123.60, which makes it a Buy.
- Sarepta Therapeutics 50-day simple moving average is 128.94 while SRPT share price is 129.88, making it a Buy technically.
- SRPT stock price is 129.88 and Sarepta Therapeutics 200-day simple moving average is 130.02, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $129.88. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
12.39B
Price in USD:
129.88
Share Volume:
736.98K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
55.25
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 129.88 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 129.88 while SRPT 8-day exponential moving average is 126.58, which is a Buy signal.
- The stock price of SRPT is 129.88 while Sarepta Therapeutics 20-day EMA is 125.36, which makes it a Buy.
- Sarepta Therapeutics 50-day exponential moving average is 128.32 while SRPT share price is 129.88, making it a Buy technically.
- SRPT stock price is 129.88 and Sarepta Therapeutics 200-day simple moving average is 127.84, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.27 per share, and an increase next year of $8.99 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 59.84, which suggest Sarepta Therapeutics is overbought
- The Bollinger Bands (25) for Sarepta Therapeutics is (120.92 - 127.2), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (122.48 - 147.12), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.